Increased mortality rate and suicide in Swedish former elite male athletes in power sports

Scandinavian Journal of Medicine and Science in Sports

Volumn 24, Issue 6, 2014, Pages 1000-1005

  Lindqvist, Ann Sophie ^a,b   Moberg, T ^a   Ehrnborg, C ^c   Eriksson, B O ^c   Fahlke, C ^a   Rosen T ^c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

AAS; Anabolic androgenic steroids malignancy; Elite athletes; Mortality; Power sports; Suicide

Indexed keywords

ANABOLIC AGENT;

ADULT; CAUSE OF DEATH; DOPING; EPIDEMIOLOGY; HUMAN; LIFESTYLE; MALE; MIDDLE AGED; MORTALITY; NEOPLASM; STATISTICS AND NUMERICAL DATA; SUICIDE; SWEDEN; TRACK AND FIELD; WEIGHT LIFTING; WRESTLING; YOUNG ADULT;

ADULT; ANABOLIC AGENTS; CAUSE OF DEATH; DOPING IN SPORTS; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; SUICIDE; SWEDEN; TRACK AND FIELD; WEIGHT LIFTING; WRESTLING; YOUNG ADULT;

EID: 84912033409     PISSN: 09057188     EISSN: 16000838     Source Type: Journal    
DOI: 10.1111/sms.12122     Document Type: Article

References (42)

1. Adami PE, Negro A, Lala N, Martelletti P. The role of physical activity in the prevention and treatment of chronic diseases. Clin Ter 2010: 161 (6): 537-541.
2. Baum A. Suicide in athletes. A review and commentary. Clin Sports Med 2005: 24 (4): 853-869.
3. Berendonk B. Doping Dokumente. Von der Forschung zum Betrag. Heidelberg, New York: Springer Verlag Berlin, 1991: 1-492.
4. Blum K, Braverman ER, Holder JM, Lubar JF, Monastra VJ, Miller D, Lubar JO, Chen TJ, Comings DE. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive Drugs 2000: 32 (Suppl i-iv): 1-112.
5. Bower B. Pumped up and strong out. Sci News 1991: 140 (2): 30-31.
6. Byberg L, Melhus H, Gedeborg R. Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. Br J Sports Med 2009: 43 (7): 482-488.
7. Cooper CJ, Noakes TD, Dunne T, Lambert MI, Rochford K. A high prevalence of abnormal personality traits in chronic users of anabolic-androgenic steroids. Br J Sports Med 1996: 30: 246-250.
8. Dalby J. Brief anabolic steroid use and sustained behavioral reaction. Am J Psychiatry 1992: 149: 271-272.
9. De Mérode A. Doping tests at the Olympic games in 1976. J Sports Med 1979: 19: 91-96.
10. Dumesnil H, Verger P. Public awareness campaigns about depression and suicide: a review. Psychiatr Serv 2009: 60 (9): 1203-1213.
11. Fudala PJ, Weinrieb RM, Calarco JS, Kampman KM, Boardman C. An evaluation of anabolic-androgenic steroid abusers over a period of 1 year: seven case studies. Ann Clin Psychiatry 2003: 15 (2): 121-130.
12. Galligani N, Renck A, Hansen S. Personality profile of men using anabolic androgenic steroids. Horm Behav 1996: 30: 170-175.
13. Hallagan JB, Hallagan LF, Snyder MB. Anabolic-Androgenic Steroid Use by Athletes. N Engl J Med 1989: 321: 1042-1045.
14. Hartgens F, Cheriex EC, Kuipers H. Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes. Int J Sports Med 2003: 24: 344-351.
15. Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Review. Sports Med 2004: 34 (8): 513-554.
16. Hawton K, van Heeringen K. Suicide. Lancet 2009: 373 (9672): 1372-1381.
17. Lee I-M, Hsieh C-C, Paffenbarger RS. Exercise intensity and longevity in men: the Harvard Alumni Health Study. JAMA 1995: 273: 1179-1184.
18. Lindqvist A-S, Moberg T, Eriksson BO, Ehrnborg C, Rosén T, Fahlke C. A retrospective 30-years follow-up study of former Swedish elite male athletes in power sports with a past anabolic androgenic steroids use: a focus on mental health. Br J Sports Med 2013: doi: 10.1136/bjsports-2012-091340.
19. Ljungqvist A. The use of anabolic steroids in top Swedish athletes. Br J Sports Med 1975: 9 (2): 82.
20. Malcolm D, Scott A. Suicide, sport and medicine. Br J Sports Med 2012: 46: 1092-1093.
21. Paffenbarger RS, Hyde RT, Wing AL, Hsieh CC. Physical activity, all cause mortality and longevity of college alumni. N Engl J Med 1986: 314: 605-613.
22. Palatini P, Giada F, Garavelli G, Sinisi F, Mario L, Michieletto M, Baldo-Enzi G. Cardiovascular effect of anabolic steroids in weight-trained subjects. J Clin Pharmacol 1996: 36 (12): 1132-1140.
23. Parkinson AB, Evans NA. Anabolic androgenic steroids: a survey of 500 users. Med Sci Exerc 2006: 38: 644-651.
24. Pärssinen M, Kujala U, Vartiainen E, Sarna S, Seppälä T. Increased premature mortality of competitive powerlifters suspected to have used anabolic steroids. Int J Sports Med 2000: 21: 225-227.
25. Pärssinen M, Seppälä T. Steroid use and long-term health risks in former athletes. Sports Med 2002: 32: 83-94.
26. Pedersen-Klarlund B, Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports 2006: 16 (1): 3-63.
27. Pekkanen JB, Marti A, Nissinen J, Tuomilehto S, Punsar S, Karvonen MJ. Reduction of premature mortality by high physical activity: a 20-year follow-up of middle-aged Finnish men. Lancet 1987: 329 (8548): 1473-1477.
28. Perry HM, Hughes GW. A case of affective disorder associated with the misuse of 'anabolic steroids'. Br J Sports Med 1992: 26: 219-220.
29. Perry PJ, Kutscher EC, Lund BC, Yates WR, Holman TL, Demers L. Measures of aggression and mood changes in male weightlifters with and without androgenic anabolic steroid use. J Forensic Sci 2003: 48 (3): 646-651.
30. Pope HG, Katz DL. Homicide and near-homicide by anabolic steroid users. J Clin Psychiatry 1990: 51: 28-31.
31. Porcerelli JH, Sandler BA. Narcissism and empathy in steroid users. Am J Psychiatry 1995: 152: 1672-1674.
32. Rizzuto D, Orsini N, Qiu C, Wang H-X, Fratiglioni L. Lifestyle, social factors, and survival after age 75: population based study. BMJ 2012: 345: 5569.
33. Robsahm T, Hestvik U, Veierod M, Fagerlie A, Nystad W, Engebretsen L, Tretli S. Cancer risk in Norwegian world class athletes. Cancer Causes Control 2010: 21: 1711-1719.
34. Sanchis-Gomar F, Olaso-Gonzalez G, Corella D, Gomez-Cabrera MC, Vina J. Increased average longevity among "Tour de France" cyclists. Int J Sports Med 2011: 32 (8): 644-647.
35. Sarna S, Sahi T, Koskenouo M, Kaprio J. Increased life expectancy of world class male athletes. Med Sci Sports Exerc 1993: 25 (2): 237-244.
36. Stanley A, Ward M. Anabolic steroids - the drugs that give and take away manhood. A case with an unusual physical sign. Med Sci Law 1994: 34: 82-83.
37. Su TP, Pagliaro M, Schmidt PJ, Pickar D, Wolkowitz O, Rubinow DR. Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA 1993: 269: 2760-2674.
38. Teramoto M, Bungum TJ. Mortality and longevity of elite athletes. J Sci Med Sport 2010: 13 (4): 410-416.
39. Thiblin I, Lindquist O, Rajs J. Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 2000: 45: 16-23.
40. Thiblin I, Runeson B, Rajs J. Anabolic androgenic steroids and suicide. Ann Clin Psychiatry 1999: 116: 223-231.
41. Yates WR, Perry P, Murray S. Aggression and hostility in anabolic steroid users. Biol Psychiatry 1992: 31 (12): 1232-1234.
42. Yesalis C, Herrick R, Buckley W, Friedl K, Brannon D, Wright J. Self-reported use of anabolic-androgenic steroids by elite power lifters. Phys Sportsmed 1988: 16: 91-100.